Investigators compared vaccine responses in Phase I and II studies in humans utilizing various combinations of DNA/vector, vector/vector and DNA/protein HIV vaccines.
[PLoS Pathogens]
Sorry, but the selected Zotpress account can't be found.
Sorry, but the selected Zotpress account can't be found.